Join to View Full Profile
Tisch Cancer CenterNew York, NY 10029
Dr. Berwick is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Harvard Medical SchoolClass of 2016
Certifications & Licensure
MA State Medical License 2022 - 2027
NY State Medical License 2019 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 5 citationsHemophagocytic lymphohistiocytosis associated with immune checkpoint inhibitor use: A review of the current knowledge and future directions.Charlotte S Walmsley, Zachary Schoepflin, Charlotte De Brabandt, Deepa Rangachari, Shana Berwick
Blood Cells, Molecules & Diseases. 2025-02-01 - CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature.Charlotte S Walmsley, Michael Andersen, Barbara Lam, Deepa Rangachari, Shana Berwick
Journal of the National Comprehensive Cancer Network. 2024-04-05 - CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature.Charlotte S Walmsley, Michael Andersen Jr, Barbara Lam, Deepa Rangachari, Shana Berwick
Journal of the National Comprehensive Cancer Network. 2024-04-05
Press Mentions
Experts Available and Research to Be Presented in Bladder Cancer, Disparities in Cancer and Other Areas at the 2021 ASCO Annual MeetingMay 19th, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
